Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Pyrobaculum arsenaticum Alanine--tRNA ligase (alaS), partial CSB-YP395064PZU
CSB-EP395064PZU
CSB-BP395064PZU
CSB-MP395064PZU
CSB-EP395064PZU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrobaculum arsenaticum DNA-directed RNA polymerase subunit D (rpoD) CSB-YP395065PZU
CSB-EP395065PZU
CSB-BP395065PZU
CSB-MP395065PZU
CSB-EP395065PZU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodobacter sphaeroides 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase (dapD) CSB-YP395066RLG
CSB-EP395066RLG
CSB-BP395066RLG
CSB-MP395066RLG
CSB-EP395066RLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodobacter sphaeroides Ribosome maturation factor RimM (rimM) CSB-YP395067RLG
CSB-EP395067RLG
CSB-BP395067RLG
CSB-MP395067RLG
CSB-EP395067RLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodobacter sphaeroides Adenine deaminase (ade), partial CSB-YP395068RLG
CSB-EP395068RLG
CSB-BP395068RLG
CSB-MP395068RLG
CSB-EP395068RLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodobacter sphaeroides Recombination protein RecR (recR) CSB-YP395069RLG
CSB-EP395069RLG
CSB-BP395069RLG
CSB-MP395069RLG
CSB-EP395069RLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodobacter sphaeroides UPF0262 protein Rsph17025_0594 (Rsph17025_0594) CSB-YP395070RLG
CSB-EP395070RLG
CSB-BP395070RLG
CSB-MP395070RLG
CSB-EP395070RLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodobacter sphaeroides Phosphoglucosamine mutase (glmM) CSB-YP395071RLG
CSB-EP395071RLG
CSB-BP395071RLG
CSB-MP395071RLG
CSB-EP395071RLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodobacter sphaeroides Protein MraZ (mraZ) CSB-YP395072RLG
CSB-EP395072RLG
CSB-BP395072RLG
CSB-MP395072RLG
CSB-EP395072RLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodobacter sphaeroides Threonine--tRNA ligase (thrS), partial CSB-YP395073RLG
CSB-EP395073RLG
CSB-BP395073RLG
CSB-MP395073RLG
CSB-EP395073RLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodobacter sphaeroides Urease subunit alpha (ureC), partial CSB-YP395074RLG
CSB-EP395074RLG
CSB-BP395074RLG
CSB-MP395074RLG
CSB-EP395074RLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodobacter sphaeroides Light-independent protochlorophyllide reductase iron-sulfur ATP-binding protein (bchL) CSB-YP395075RLG
CSB-EP395075RLG
CSB-BP395075RLG
CSB-MP395075RLG
CSB-EP395075RLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodobacter sphaeroides Phosphoglycerate kinase (pgk) CSB-YP395076RLG
CSB-EP395076RLG
CSB-BP395076RLG
CSB-MP395076RLG
CSB-EP395076RLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodobacter sphaeroides ATP-dependent Clp protease proteolytic subunit (clpP) CSB-YP395077RLG
CSB-EP395077RLG
CSB-BP395077RLG
CSB-MP395077RLG
CSB-EP395077RLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodobacter sphaeroides 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase (ispD) CSB-YP395078RLG
CSB-EP395078RLG
CSB-BP395078RLG
CSB-MP395078RLG
CSB-EP395078RLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodobacter sphaeroides Phosphate acyltransferase (plsX) CSB-YP395079RLG
CSB-EP395079RLG
CSB-BP395079RLG
CSB-MP395079RLG
CSB-EP395079RLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodobacter sphaeroides Cysteine--tRNA ligase (cysS) CSB-YP395080RLG
CSB-EP395080RLG
CSB-BP395080RLG
CSB-MP395080RLG
CSB-EP395080RLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodobacter sphaeroides 50S ribosomal protein L13 (rplM) CSB-YP395081RLG
CSB-EP395081RLG
CSB-BP395081RLG
CSB-MP395081RLG
CSB-EP395081RLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodobacter sphaeroides ATP synthase gamma chain (atpG) CSB-YP395082RLG
CSB-EP395082RLG
CSB-BP395082RLG
CSB-MP395082RLG
CSB-EP395082RLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodobacter sphaeroides Imidazole glycerol phosphate synthase subunit HisF (hisF) CSB-YP395083RLG
CSB-EP395083RLG
CSB-BP395083RLG
CSB-MP395083RLG
CSB-EP395083RLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>